These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 386320
1. Detection of antidonor antibody: advantages of fibroblast target cells. Halloran PF, Aprile M, Haddad G, Robinette M. Proc Clin Dial Transplant Forum; ; 8():49-55. PubMed ID: 386320 [Abstract] [Full Text] [Related]
2. Donor-specific antibodies in renal allograft recipients. A reevaluation of the 51Cr-release assays comparing fibroblast and lymphoid target cells. Halloran PF, Aprile M, Haddad G, Cunningham K, Robinette MA. Transplantation; 1984 Apr; 37(4):356-8. PubMed ID: 6369664 [Abstract] [Full Text] [Related]
5. The correlation of kidney transplant survival with lymphocyte mediated cytotoxicity on B cell targets. Nathan P, Plessinger RT, First MR. Proc Clin Dial Transplant Forum; 1976 Apr 29; 8():62-7. PubMed ID: 386322 [Abstract] [Full Text] [Related]
6. Alloantibodies and outcomes of deceased donor kidney allografts. Cinti P, Pretagostini R, Lai Q, Tamburro ML, Rossi M, Poli L, Berloco P. Hum Immunol; 2009 Aug 29; 70(8):651-4. PubMed ID: 19527761 [Abstract] [Full Text] [Related]
13. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function. Nickel P, Bold G, Presber F, Biti D, Babel N, Kreutzer S, Pratschke J, Schönemann C, Kern F, Volk HD, Reinke P. Transpl Immunol; 2009 Mar 29; 20(4):238-42. PubMed ID: 19032982 [Abstract] [Full Text] [Related]
14. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Halloran PF, Schlaut J, Solez K, Srinivasa NS. Transplantation; 1992 Mar 29; 53(3):550-5. PubMed ID: 1549846 [Abstract] [Full Text] [Related]
15. Donor-specific cell-mediated cytotoxicity in renal allograft recipients. Dickmeiss E. Acta Pathol Microbiol Scand C; 1979 Dec 29; 87(6):371-76. PubMed ID: 397716 [Abstract] [Full Text] [Related]
17. In vitro cytotoxicity by human lymphocytes from individuals immunized against histocompatibility antigens. II. Relation to HL-A incompatibility between effector and target cells. Lundgren G, Möller E, Thorsby E. Clin Exp Immunol; 1970 May 29; 6(5):671-80. PubMed ID: 4920602 [Abstract] [Full Text] [Related]
19. Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis. Burlingham WJ, Jankowska-Gan E, VanBuskirk A, Orosz CG, Lee JH, Kusaka S. Hum Immunol; 2000 Dec 29; 61(12):1395-402. PubMed ID: 11163098 [Abstract] [Full Text] [Related]
20. Alloantibodies and the outcome of cadaver kidney allografts. Vasilescu ER, Ho EK, Colovai AI, Vlad G, Foca-Rodi A, Markowitz GS, D'Agati V, Hardy MA, Ratner LE, Suciu-Foca N. Hum Immunol; 2006 Aug 29; 67(8):597-604. PubMed ID: 16916655 [Abstract] [Full Text] [Related] Page: [Next] [New Search]